Concerns About Compounded Bioidentical Menopausal Hormone Therapy
Unlike the CPT codes that are effective January 1 and are included in the OPPS/ASC proposed rules, and except for the proposed new C-codes and G-codes listed in Addendum O of the CY 2026 OPPS/ASC proposed rule, most Level II HCPCS codes are not released until sometime around November to be effective January 1
Avoid injecting into: Skin that is bruised, tender, scarred, or affected by a rash Areas with visible lipohypertrophy or lipoatrophy (sunken skin) The waistband area or near bony prominences If you notice persistent lumps, skin changes, or unusual discomfort at injection sites, report these to your healthcare professional promptly
For those considering these medications, leveraging modern telehealth platforms like Doctronic.ai can provide timely, evidence-based guidance tailored to individual needs
up to 60% of consumers report that healthy aging is a top or very important priority for them